Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obesity and Weight Loss.

European cardiology·2019
Same author

Non-PCI/CABG therapies for refractory angina.

Trends in cardiovascular medicine·2017
Same author

Prognostic Significance of Asymptomatic Myocardial Ischemia in Women vs. Men.

Current pharmaceutical design·2016
Same author

Coronary Artery Calcium Scanning: Past, Present, and Future.

JACC. Cardiovascular imaging·2016
Same author

Editorial Commentary: Statins and acute coronary syndromes.

Trends in cardiovascular medicine·2016
Same author

Ranolazine in Cardiac Arrhythmia.

Clinical cardiology·2015

Related Experiment Video

Updated: Jun 21, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Some clinical trials get no respect.

C Richard Conti

    Clinical Cardiology
    |July 18, 2009
    PubMed
    Summary

    Randomized clinical trials comparing medical therapy to revascularization (PCI/stent or bypass surgery) can be misinterpreted. Physician bias and media hype often obscure trial findings, delaying clear understanding.

    Area of Science:

    • Cardiovascular Medicine
    • Clinical Trial Analysis
    • Medical Intervention Efficacy

    Background:

    • Randomized clinical trials (RCTs) provide valuable data, but their interpretation can be challenging.
    • Trials comparing medical therapy with revascularization procedures (e.g., percutaneous coronary intervention/stent or coronary artery bypass surgery) are prone to significant bias.
    • Misinterpretation by healthcare professionals and the media can lead to premature conclusions and public confusion.

    Discussion:

    • Physician bias can influence the perception and application of trial results.
    • The lay press often sensationalizes trial outcomes, creating 'heat' without sufficient 'light' or clear evidence.
    • This phenomenon is particularly evident in studies evaluating the comparative effectiveness of medical management versus invasive revascularization strategies.

    More Related Videos

    In Silico Clinical Trials for Cardiovascular Disease
    09:09

    In Silico Clinical Trials for Cardiovascular Disease

    Published on: May 27, 2022

    Related Experiment Videos

    Last Updated: Jun 21, 2026

    A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
    04:53

    A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

    Published on: September 20, 2019

    In Silico Clinical Trials for Cardiovascular Disease
    09:09

    In Silico Clinical Trials for Cardiovascular Disease

    Published on: May 27, 2022

    Key Insights:

    • Objective interpretation of RCTs is crucial for advancing cardiovascular care.
    • Distinguishing between genuine scientific illumination and biased or sensationalized reporting is essential.
    • Understanding the impact of bias on trial perception is key to evidence-based practice.

    Outlook:

    • Future research should focus on methodologies to mitigate bias in clinical trial reporting.
    • Enhanced communication strategies are needed to ensure accurate dissemination of trial findings to clinicians and the public.
    • Promoting critical appraisal skills within the cardiovascular community can improve the understanding of complex trial data.